Key Metrics
CiteScore 

6.3
H-Index 

42
Impact Factor 

< 5
SJR 

Q2Pharmacology (medical)

SNIP 

1.67
Recommended pre-submission checks
Powered by 

Topics Covered on Therapeutic Advances in Drug Safety
Therapeutic Advances in Drug Safety Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2200 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Therapeutic Advances in Drug Safety ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Therapeutic Advances in Drug Safety
Development and validation of a MedDRA-based signal detection construct for drug-induced neurobehavioral impairment
- 3 Aug 2026
- Therapeutic Advances in Drug Safety
Disproportionality analysis of off-label intravitreal bevacizumab in the FDA Adverse Event Reporting System database
- 28 Jul 2026
- Therapeutic Advances in Drug Safety
Development and prospective validation of a machine learning model for risk stratification of drug-induced liver injury using real-world clinical data
- 25 Jul 2026
- Therapeutic Advances in Drug Safety
Safety of belimumab during pregnancy: associations with maternal and fetal or newborn adverse outcomes based on FAERS data
- 18 Jun 2026
- Therapeutic Advances in Drug Safety
Detection of clinically significant drug-drug interactions in serotonin syndrome: a multisource real-world data and pharmacovigilance study
- 16 Jun 2026
- Therapeutic Advances in Drug Safety
A descriptive, retrospective analysis of the quality of spontaneous adverse event reporting to the C\xf4te d\u2019Ivoire Pharmaceutical and Regulatory Authority and its impact on the causality assessment
- 8 Jun 2026
- Therapeutic Advances in Drug Safety
Development and validation of a MedDRA-based signal detection construct for drug-induced neurobehavioral impairment
- 3 Aug 2026
- Therapeutic Advances in Drug Safety
Disproportionality analysis of off-label intravitreal bevacizumab in the FDA Adverse Event Reporting System database
- 28 Jul 2026
- Therapeutic Advances in Drug Safety
Development and prospective validation of a machine learning model for risk stratification of drug-induced liver injury using real-world clinical data
- 25 Jul 2026
- Therapeutic Advances in Drug Safety
Safety of belimumab during pregnancy: associations with maternal and fetal or newborn adverse outcomes based on FAERS data
- 18 Jun 2026
- Therapeutic Advances in Drug Safety
Detection of clinically significant drug-drug interactions in serotonin syndrome: a multisource real-world data and pharmacovigilance study
- 16 Jun 2026
- Therapeutic Advances in Drug Safety
A descriptive, retrospective analysis of the quality of spontaneous adverse event reporting to the C\xf4te d\u2019Ivoire Pharmaceutical and Regulatory Authority and its impact on the causality assessment
- 8 Jun 2026
- Therapeutic Advances in Drug Safety